WSK IM05
Alternative Names: WSK-IM05Latest Information Update: 08 Sep 2021
At a glance
- Originator Westvac Biopharma
- Class Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 26 Aug 2021 Westvac Biopharma files an IND application in China for unspecified indication (Prevention) in Q4 of 2022
- 26 Aug 2021 Westvac Biopharma plans a phase I trial for Unspecified indication (Prevention) in China (IM) in Q2 of 2023
- 26 Aug 2021 Westvac Biopharma plans a phase II trial for Unspecified indication (Prevention) in China (IM) in Q4 of 2023